Carestream Health Introduces New Mobile X-Ray Device
The DRX-Rise Mobile X-ray System reportedly combines optimal image quality with enhanced maneuverability and ease of use for radiologists.
With the promise of artificial intelligence (AI)-powered image processing and features that promote workflow productivity and maneuverability, Carestream Health has launched the DRX-Rise Mobile X-ray System.
One of the features of the DRX-Rise Mobile X-ray System is Carestream Health’s AI-propelled ImageView Software, which facilitates image quality and dosing efficiency through robust image processing, according to Carestream Health.
The company said other attributes of the new X-ray system include in-bin detector charging, two touchscreen displays and new drive capabilities that help ensure optimal maneuverability and positioning at a patient’s bedside.
“The DRX-Rise Mobile X-ray System delivers high-end features that support the most critical needs in medical imaging: exceptional image quality for confident diagnosis; workflow-accelerating attributes for productivity; and a more comfortable imaging experience for patients – all without significantly impacting capital budget,” noted Jordan Berry, the global marketing manager for Carestream Health.
(Editor’s note: For related content, see “Autonomous AI Shows Nearly 27 Percent Higher Sensitivity than Radiology Reports for Abnormal Chest X-Rays” and “Canon Medical Launches New CT and X-Ray Modalities at ECR 2023.”)
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
